[HTML] from nih.govJM Scheiman, PJ Devereaux, J Herlitz, PH Katelaris… - Heart, 2011 - ncbi.nlm.nih.gov This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in ...
A Sonnenberg - Gut, 2011 - gut.bmj.com The author's response: I appreciate the comments by Drs Johnson and Fitzsimmons.1 In my opinion, three separate issues need to be emphasised when trying to understand the long-term time trends of gastric cancer, gastric ulcer and duodenal ulcer as evidenced by their ... Related articles - All 2 versions
JM Scheiman, PJ Devereaux, J Herlitz, PH Katelaris… - Heart, 2011 - heart.bmj.com Objective To determine whether once-daily esomeprazole 40 mg or 20 mg compared with placebo reduces the incidence of peptic ulcers over 26 weeks of treatment in patients taking low-dose acetylsalicylic acid (ASA) and who are at risk for ulcer development. Cited by 1 - Related articles - All 4 versions
WH Chan, LW Khin, YFA Chung… - British Journal of …, 2011 - Wiley Online Library Rebleeding from peptic ulcers is a major contributor to death. This study compared standard (40-mg intravenous infusion of omeprazole once daily for 3 days) and high-dose (80-mg bolus of omeprazole followed by 8-mg/h infusion for 72 h) in reducing the rebleeding rate ... Related articles - All 3 versions
CH Chung, EJ Kim, MY Park, SJ Choi… - The Korean Journal of …, 2011 - komci.org PURPOSE: Patients with chronic renal failure tend to have an increased incidence of peptic ulcer disease. Helicobacter pylori (H. pylori) infection is generally found to be the major cause of peptic ulcer disease. There are a few studies about the association between H. pylori and peptic ... Cached - All 2 versions